SG's Hummingbird Bioscience secures more capital in Series B extension round

SG's Hummingbird Bioscience secures more capital in Series B extension round

Antibody visual sourced from Hummingbird's website

Amid a pandemic-induced funding drought, private equity and venture capital firm Heritas Capital has stumped up extra funding for one of its deep tech startups.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter